FEMIA, ETI ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 2.809
NA - Nord America 2.561
AS - Asia 2.268
SA - Sud America 202
AF - Africa 48
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.897
Nazione #
US - Stati Uniti d'America 2.444
GB - Regno Unito 1.126
SG - Singapore 743
CN - Cina 715
IT - Italia 423
DE - Germania 258
SE - Svezia 232
HK - Hong Kong 226
RU - Federazione Russa 184
VN - Vietnam 181
BR - Brasile 149
FR - Francia 112
IN - India 110
NL - Olanda 103
IE - Irlanda 75
UA - Ucraina 71
CA - Canada 70
FI - Finlandia 55
DK - Danimarca 52
KR - Corea 47
BD - Bangladesh 46
JP - Giappone 42
TR - Turchia 38
ID - Indonesia 28
BE - Belgio 27
EU - Europa 21
MX - Messico 19
PL - Polonia 18
ES - Italia 16
AR - Argentina 15
CI - Costa d'Avorio 15
UZ - Uzbekistan 15
CO - Colombia 14
IQ - Iraq 13
AT - Austria 11
GR - Grecia 11
PH - Filippine 11
PK - Pakistan 11
AU - Australia 8
CH - Svizzera 8
CZ - Repubblica Ceca 8
JM - Giamaica 8
ZA - Sudafrica 7
TW - Taiwan 6
CL - Cile 5
CR - Costa Rica 5
IR - Iran 5
JO - Giordania 5
SA - Arabia Saudita 5
VE - Venezuela 5
KZ - Kazakistan 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
BO - Bolivia 3
EC - Ecuador 3
HR - Croazia 3
KE - Kenya 3
LU - Lussemburgo 3
MA - Marocco 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
CM - Camerun 2
GA - Gabon 2
HN - Honduras 2
IL - Israele 2
MY - Malesia 2
NG - Nigeria 2
PA - Panama 2
SY - Repubblica araba siriana 2
TG - Togo 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BJ - Benin 1
BM - Bermuda 1
BS - Bahamas 1
BZ - Belize 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GL - Groenlandia 1
GN - Guinea 1
GY - Guiana 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
PR - Porto Rico 1
Totale 7.914
Città #
Southend 1.055
Singapore 492
Ashburn 299
Chandler 295
Hong Kong 198
Milan 157
Ann Arbor 147
Beijing 125
San Jose 122
Dallas 105
Los Angeles 91
Princeton 86
Council Bluffs 77
Frankfurt am Main 77
Dublin 74
Wilmington 72
Dearborn 64
Fairfield 62
Seattle 57
Ho Chi Minh City 53
Nanjing 50
Hanoi 48
New York 46
Munich 45
Santa Clara 45
Toronto 44
Jacksonville 42
Woodbridge 42
Shanghai 41
Lauterbourg 35
Guangzhou 33
Boardman 31
Des Moines 31
Bengaluru 29
The Dalles 29
Grafing 26
Tokyo 26
Buffalo 25
Helsinki 25
Moscow 25
Redmond 25
Cambridge 23
Jinan 23
Houston 22
Mountain View 22
Brussels 19
Redwood City 19
Columbus 18
Hebei 17
Serra 17
Jakarta 16
Abidjan 15
Fuzhou 15
São Paulo 15
Sakarya 14
Tianjin 14
Andover 13
Cangzhou 13
Bogotá 12
Shenyang 12
Hangzhou 11
Phoenix 11
Seoul 11
Shenzhen 11
Athens 10
Berlin 10
Nanchang 10
Orem 10
Rome 10
San Diego 10
Chicago 9
Nuremberg 9
Strasbourg 9
Taizhou 9
Wuhan 9
Atlanta 8
Changsha 8
Copenhagen 8
Haikou 8
Medford 8
Montreal 8
Ningbo 8
Rio de Janeiro 8
Somerville 8
Zhengzhou 8
London 7
Madrid 7
Turin 7
Chennai 6
Fremont 6
Hefei 6
Paris 6
Quanzhou 6
Stockholm 6
Turku 6
Warsaw 6
Brooklyn 5
Dhaka 5
Dong Ket 5
Genoa 5
Totale 5.088
Nome #
In-vitro and in-vivo metabolism of different aspirin formulations studied by a validated liquid chromatography tandem mass spectrometry method 346
Studies of the interaction of ticagrelor with the P2Y13 receptor and with P2Y13-dependent pro-platelet formation by human megakaryocytes 332
Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome 321
Aspirin responsiveness in essential thrombocythemia 292
Complications of whole-exome sequencing for causal gene discovery in primary platelet secretion defects 264
Effect of prasugrel in patients with asthma : results of PRINA, a randomized, double-blind, placebo-controlled, cross-over study 249
Acquired platelet dysfunction and overproduction of platelet cyclic AMP in two patients with myeloid malignancies 240
Bleeding diathesis and gastro-duodenal ulcers in inherited cytosolic phospholipase-A2 alpha deficiency 239
Evaluation of aspirin responsiveness in healthy subjects and essential thrombocythemia patients 232
Synthesis of unnatural homologues of deoxypyridinoline as possible internal standards in analytical detection of pyridinolinic cross links of collagen 228
Determinazione diretta degli acidi N-Acetil e N-Glicolilneuraminico mediante HPLC/ESI-MS/MS 227
Inhibition of the platelet P2Y12 receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A2 217
Comparison of different procedures to prepare platelet-rich plasma for studies of platelet aggregation by light transmission aggregometry 216
Patients with Essential Thrombocythemia may be Poor Responders to Enteric-Coated Aspirin, but not to Plain Aspirin 211
Aggregometry in the settings of thrombocytopenia, thrombocytosis and antiplatelet therapy 210
Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia 207
Effect of platelet count on platelet aggregation measured by impedance aggregometry (Multiplate(™) analyser) and by light transmission aggregometry 202
Urinary levels of 11-dehydro-TxB2 are not an accurate marker of inhibition of platelet thromboxane A2 production by aspirin 201
Studies for a reliable and definitive identification of sialic acid 1,7-lactones in human erythrocytes membranes in polycythemia vera 199
Acetylsalicylic acid inhibits thromboxane A2 production and thromboxane A2-dependent platelet function equally well in diabetic and non-diabetic subjects 197
Direct determination of sialic acids using a stationary phase modified with alkylboronic acid and isotope dilution HPLC-MS/MS 192
Quantification of N-acetyl- and N-glycolylneuraminic acids by a stable isotope dilution assay using high-performance liquid chromatography–tandem mass spectrometry 192
Evaluation of platelet function in essential thrombocythemia under different analytical conditions 189
The platelet count in EDTA-anticoagulated blood from patients with thrombocytopenia may be underestimated when measured in routine laboratories 188
Accurate evaluation of sialic acids in biological matrices for a more reliable assessment of their role 185
Quantification of sialic acids by isotope dilution HPLC-MS/MS 184
Instability of cytosolic phospholipase A(2)alpha variant upon cellular expression as a basis for its clinical presentation 180
Congenital defects of platelet function 177
EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin 175
Inherited dysfunctional platelet P2Y12 receptor mutations associated with bleeding disorders 174
A simple strategy for the synthesis of the glycosylated collagen biomarkers alfa-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl-O-pyridinoline (Glc-Gal-PYD), alfa-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl-5-O-hydroxylysine (Glc-Gal-Hyl) and of their unnatural epimers Glc-Gal-epiPYD and Glc-Gal-epiHyl 172
Simultaneous determination of underivatized O-acetylated sialic acids by HPLC-MS 162
Zonisamide in the management of epilepsy in the elderly 158
Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism 149
Effects of pH and concentration of sodium citrate anticoagulant on platelet aggregation measured by light transmission aggregometry induced by adenosine diphosphate 146
P2Y12 receptor gene mutations associated with bleeding 144
Usefulness of the INNOVANCE® PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y12 receptor for adenosine diphosphate 138
Reduced platelet count, but no major platelet function abnormalities, are associated with loss of function ATP-binding cassette-1 (ABCA1) gene mutations 137
Current and emerging approaches for evaluating platelet disorders 131
Ticagrelor for left ventricular assist device thrombosis : A new therapeutic option to be evaluated with caution 109
Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes : results of the switch over trial 99
Novel variant in HPS3 gene in a patient with Hermansky Pudlak syndrome (HPS) type 3 48
Totale 8.259
Categoria #
all - tutte 21.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021139 0 0 0 0 0 0 0 0 0 0 85 54
2021/2022624 47 43 24 42 37 19 42 30 92 47 50 151
2022/2023808 113 119 74 86 88 163 16 63 52 8 16 10
2023/2024392 13 37 24 23 76 37 15 31 11 23 41 61
2024/20251.238 51 87 26 175 95 42 20 119 68 147 137 271
2025/20262.253 255 130 235 196 262 155 361 108 211 183 157 0
Totale 8.259